Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LOPERAMIDE | 2MG | TABLET | Actual shortage | 2017-03-10 | 2017-10-05 | 372 |
| APO-LORATADINE | 10MG | TABLET | Resolved | 2025-01-09 | 2025-04-17 | 247397 |
| APO-LORAZEPAM | 0.5MG | TABLET | Resolved | 2024-04-12 | 2024-04-26 | 225014 |
| APO-LORAZEPAM | 0.5MG | TABLET | Resolved | 2024-06-27 | 2024-09-20 | 231484 |
| APO-LORAZEPAM | 1MG | TABLET | Resolved | 2024-07-12 | 2024-09-20 | 232846 |
| APO-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-03-10 | 2017-08-08 | 375 |
| APO-LORAZEPAM | 0.5MG | TABLET | Resolved | 2021-06-18 | 2021-09-20 | 141244 |
| APO-LORAZEPAM | 1MG | TABLET | Resolved | 2017-10-23 | 2018-01-22 | 26594 |
| APO-LORAZEPAM | 1MG | TABLET | Resolved | 2018-03-20 | 2018-06-12 | 43511 |
| APO-LORAZEPAM | 2MG | TABLET | Resolved | 2020-08-12 | 2020-10-05 | 122071 |
| APO-LORAZEPAM | 2MG | TABLET | Resolved | 2021-08-03 | 2021-09-07 | 143401 |
| APO-LORAZEPAM | 2MG | TABLET | Resolved | 2021-12-01 | 2021-12-20 | 150252 |
| APO-LORAZEPAM | 2MG | TABLET | Resolved | 2022-04-01 | 2022-05-13 | 157698 |
| APO-LOSARTAN | 50MG | TABLET | Resolved | 2017-03-12 | 2017-03-16 | 722 |
| APO-LOSARTAN | 50MG | TABLET | Actual shortage | 2018-05-01 | 2019-03-15 | 47652 |
| APO-LOSARTAN | 100MG | TABLET | Actual shortage | 2018-05-15 | 2019-04-11 | 49490 |
| APO-LOSARTAN | 25MG | TABLET | Actual shortage | 2018-07-11 | 2019-03-15 | 55284 |
| APO-LOSARTAN | 100MG | TABLET | Actual shortage | 2018-12-27 | 2019-04-17 | 70523 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2017-10-24 | 2018-09-11 | 26827 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2018-02-13 | 2018-09-10 | 39656 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |